Li Zhe,Chang Nuan*,Li Li.The Policy History, Present Situation and Countermeasures of Chinese Medicine Hospital Preparations[J].Chinese Journal of Library and Information Science for Traditional Chinese Medicine,2014,38(1):38-41.[doi:10.3969/j.issn.2095-5707.2014.01.012]
中药院内制剂政策历史、现状及对策
- Title:
- The Policy History, Present Situation and Countermeasures of Chinese Medicine Hospital Preparations
- 文献标志码:
- A
- 摘要:
- 院内制剂在保障临床用药、满足医疗科研需要等方面起着重要作用。为更好促进中医药事业发展，本文立足于我国中药院内制剂政策历史、现状，着重分析了现行的院内中药制剂审批政策对于中医发展的影响，剖析了其中存在的问题，并据此提出相应的对策和建议。
- Abstract:
- Hospital preparations play an important role in guaranteeing clinical medication and meeting medical research. In order to promote the development of Chinese medicine, this paper focuses on the impact of the existing policy on the development of Chinese medicine hospital medicine based on Traditional Chinese Medicine hospital preparations policy history and current situation. And then, we analyze the existing problems and put forward corresponding countermeasures and suggestions.
参考文献/References:
?[1]甄志亚.中国医学史[M].2版.上海：上海科学技术出版社，1997:58-61,77. [2]陈峰，曹彩，刘新民.我国中药技术标准管理体制的历史与现状—中药技术标准管理体制的战略研究系列（Ⅰ）[J].世界科学技术—中医药现代化,2004,6(4):1-9. [3]杨见瑞.祁州中药志[M].2版.河北：河北科学技术出版社，1987:18. [4]王方升.中药制剂工艺研究存在的问题与对策[J].中国药事,2009,23(1):52-55. [5]李光耀，毕开顺.中药新药研发策略刍议[J].中国药业,2008,17(12):261-263. [6]杨晓艳.浅谈中药管理中存在的问题及对策[J].齐鲁药事,2009,28(1):10-12.
相似文献/References:
[1]史磊,曹思思.基于利水功效组群药物的中药药性规律研究[J].中国中医药图书情报杂志,2014,38(4):10.[doi:10.3969/j.issn.2095-5707.2014.04.003]
Shi Lei,Cao Sisi.A Study on Regularity of the Property of Chinese Materia Medica Based on Group Drugs with Diuretic Efficacy[J].Chinese Journal of Library and Information Science for Traditional Chinese Medicine,2014,38(1):10.[doi:10.3969/j.issn.2095-5707.2014.04.003]
[2]林敏华,吴昊,曾华敏,等.中药提取物及有效成分防治非酒精性脂肪性肝病的作用机制研究进展[J].中国中医药图书情报杂志,2020,44(1):72.[doi:10.3969/j.issn.2095-5707.2020.01.017]
LIN Min-hua,WU Hao,ZENG Hua-min,et al.Research Progress in Mechanism of Action of Chinese Materia Medica Extracts and Active Components for Prevention and Treatment of Nonalcoholic Fatty Liver Disease[J].Chinese Journal of Library and Information Science for Traditional Chinese Medicine,2020,44(1):72.[doi:10.3969/j.issn.2095-5707.2020.01.017]
[3]黄凯文,刘芳.岭南医家江勒卿与《药物学注释》[J].中国中医药图书情报杂志,2020,44(4):48.[doi:10.3969/j.issn.2095-5707.2020.04.012]
HUANG Kai-wen,LIU Fang.Lingnan Doctor Jiang Le-qing and Yao Wu Xue Zhu Shi[J].Chinese Journal of Library and Information Science for Traditional Chinese Medicine,2020,44(1):48.[doi:10.3969/j.issn.2095-5707.2020.04.012]
[4]郝雨培,崔妍彧,赵若楠,等.中药治疗子宫肌瘤的作用机制研究进展[J].中国中医药图书情报杂志,2021,45(4):69.[doi:10.3969/j.issn.2095-5707.2021.04.017]
HAO Yu-pei,CUI Yan-yu,ZHAO Ruo-nan,et al.Research Progress in Mechanism of Chinese Materia Medica in the Treatment of Uterine Leiomyoma[J].Chinese Journal of Library and Information Science for Traditional Chinese Medicine,2021,45(1):69.[doi:10.3969/j.issn.2095-5707.2021.04.017]
[5]蒋志雄,朱智德*,祁祥,等.中药联合环磷腺苷葡胺治疗病毒性心肌炎的Meta分析[J].中国中医药图书情报杂志,2021,45(5):13.[doi:10.3969/j.issn.2095-5707.2021.05.003]
JIANG Zhi-xiong,ZHU Zhi-de*,QI Xiang,et al.Meta-analysis on Chinese Materia Medica Combined with Meglumine Adenosine Cyclphosphate in the Treatment of Viral Myocarditis[J].Chinese Journal of Library and Information Science for Traditional Chinese Medicine,2021,45(1):13.[doi:10.3969/j.issn.2095-5707.2021.05.003]
[6]支晓娟.粤港澳大湾区中药专利分析与思考[J].中国中医药图书情报杂志,2021,45(6):18.[doi:10.3969/j.issn.2095-5707.2021.06.004]
ZHI Xiao-juan.Analysis and Thinking on Patent of Chinese Materia Medica in Guangdong-Hong Kong-Macao Greater Bay Area[J].Chinese Journal of Library and Information Science for Traditional Chinese Medicine,2021,45(1):18.[doi:10.3969/j.issn.2095-5707.2021.06.004]
备注/Memo
收稿日期：2013-08-29
更新日期/Last Update:
2014-01-21